Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare ...
Business Wire

ResMed Completes $225 Million Acquisition of Propeller Health

SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has ...
Seeking Alpha

Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026

Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis Gross margin up 290 bps to 61.5%; non-GAAP gross margin up 280 bps to 62.0% Income from operations increased 15%; non-GAAP ...
Business Wire

ResMed Debuts MaskSelector, a Digital Tool for Remote CPAP Mask Fittings

SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) has launched ResMed MaskSelector, a digital tool to make remote patient mask selection and sizing easier and more effective, helping patients ...
Yahoo Finance

ResMed Launches AirSense 11 PAP Series, Advancing Digital Health in Sleep Apnea Treatment

Personal Therapy Assistant feature for AirSense 11 users, seen here within the myAir app SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ResMed, a global leader in digital health and sleep apnea ...
Nasdaq

ResMed Announces Q2 Fiscal Year 2025 Financial Results Release and Webcast Details

ResMed announced it will release its financial and operational results for the second quarter of fiscal year 2025 on January 30, 2025, after the stock market closes. Following the release, management ...
Nasdaq

ResMed Reveals Global Sleep Crisis: New Survey Highlights Impact on Health, Productivity, and Relationships

ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the average ...
manilatimes

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ...
Financial Post

Resmed Acquires VirtuOx

Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) — Resmed ...
Seeking Alpha

ResMed: Safe Bet For A Recession Environment

ResMed is rated a buy due to strong fundamentals, expanding margins, robust cash flow, and resilience in recessionary environments. RMD's steady topline growth, high profitability, low debt, and ...